Aprea Therapeutics Statistics

Total Valuation

APRE has a market cap or net worth of $8.40 million. The enterprise value is -$10.76 million.

Market Cap	8.40M
Enterprise Value	-10.76M

Important Dates

The last earnings date was Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

APRE has 5.49 million shares outstanding. The number of shares has increased by 54.69% in one year.

Current Share Class	5.49M
Shares Outstanding	5.49M
Shares Change (YoY)	+54.69%
Shares Change (QoQ)	+0.66%
Owned by Insiders (%)	11.84%
Owned by Institutions (%)	18.07%
Float	3.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.50
Forward PS	n/a
PB Ratio	0.43
P/TBV Ratio	0.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.90

Current Ratio	5.90
Quick Ratio	5.73
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -59.80% and return on invested capital (ROIC) is -40.49%.

Return on Equity (ROE)	-59.80%
Return on Assets (ROA)	-35.70%
Return on Invested Capital (ROIC)	-40.49%
Return on Capital Employed (ROCE)	-90.48%
Revenue Per Employee	$160,559
Profits Per Employee	-$1.76M
Employee Count	8
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.63% in the last 52 weeks. The beta is 1.64, so APRE's price volatility has been higher than the market average.

Beta (5Y)	1.64
52-Week Price Change	-72.63%
50-Day Moving Average	1.90
200-Day Moving Average	3.02
Relative Strength Index (RSI)	36.95
Average Volume (20 Days)	20,389

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, APRE had revenue of $1.28 million and -$14.08 million in losses. Loss per share was -$2.37.

Revenue	1.28M
Gross Profit	-8.08M
Operating Income	-15.26M
Pretax Income	-12.72M
Net Income	-14.08M
EBITDA	-15.23M
EBIT	-15.26M
Loss Per Share	-$2.37

Full Income Statement

Balance Sheet

The company has $19.28 million in cash and n/a in debt, giving a net cash position of $19.28 million or $3.51 per share.

Cash & Cash Equivalents	19.28M
Total Debt	n/a
Net Cash	19.28M
Net Cash Per Share	$3.51
Equity (Book Value)	16.86M
Book Value Per Share	2.82
Working Capital	16.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$13.25 million and capital expenditures -$7,500, giving a free cash flow of -$13.26 million.

Operating Cash Flow	-13.25M
Capital Expenditures	-7,500
Free Cash Flow	-13.26M
FCF Per Share	-$2.41

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,187.69%
Pretax Margin	-1,096.27%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.69%
Shareholder Yield	-54.69%
Earnings Yield	-165.42%
FCF Yield	-155.76%

Analyst Forecast

The average price target for APRE is $15.50, which is 913.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.50
Price Target Difference	913.07%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	140.25%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2